-
M596353-50mgAnsamitocin P-3 (AP-3) is an active and potent anti-tumor maytansinoid, which is produced by Actinosynnema spp. Ansamitocin P-3 showed potent cytotoxicity against the human solid tumor cell lines A-549, HT-29. Ansamitocin P-3 is a useful material to
-
M596948-1gMBS is a heterobifunction crosslinker that contains a maleimide group which is reactive towards sulfhydryls and an NHS ester, useful for targeting amine groups.
-
M596948-250mgMBS is a heterobifunction crosslinker that contains a maleimide group which is reactive towards sulfhydryls and an NHS ester, useful for targeting amine groups.
-
M596948-500mgMBS is a heterobifunction crosslinker that contains a maleimide group which is reactive towards sulfhydryls and an NHS ester, useful for targeting amine groups.
-
M597214-100mgMC (C5)-Val-Cit is a cleavable ADC linker. The Val-Cit will specifically be cleaved by Cathepsin B. As this enzyme is only present in the lysosome, the ADC payload will be released only in the cell.
-
M597214-250mgMC (C5)-Val-Cit is a cleavable ADC linker. The Val-Cit will specifically be cleaved by Cathepsin B. As this enzyme is only present in the lysosome, the ADC payload will be released only in the cell.
-
M597214-500mgMC (C5)-Val-Cit is a cleavable ADC linker. The Val-Cit will specifically be cleaved by Cathepsin B. As this enzyme is only present in the lysosome, the ADC payload will be released only in the cell.
-
M596644-10mgMC-MMAF is a precursor of antibody drug conjugate. This compound uses a maleimidocaproyl (MC) spacer and uses MMAF which is a synthetic antineoplastic agent.
-
M596644-1mgMC-MMAF is a precursor of antibody drug conjugate. This compound uses a maleimidocaproyl (MC) spacer and uses MMAF which is a synthetic antineoplastic agent.
-
M596644-5mgMC-MMAF is a precursor of antibody drug conjugate. This compound uses a maleimidocaproyl (MC) spacer and uses MMAF which is a synthetic antineoplastic agent.
-
M597246-10mgMC-Val-Cit-Doxorubicin is a precursor of antibody drug conjugate. The maleimide can conjugate with thiol containing molecules.
-
M597246-25mgMC-Val-Cit-Doxorubicin is a precursor of antibody drug conjugate. The maleimide can conjugate with thiol containing molecules.